Other OTC - Delayed Quote USD

ZIVO Bioscience, Inc. (ZIVO)

8.00 0.00 (0.00%)
As of April 19 at 12:46 PM EDT. Market Open.
Loading Chart for ZIVO
DELL
  • Previous Close 8.00
  • Open 7.30
  • Bid --
  • Ask --
  • Day's Range 8.00 - 8.00
  • 52 Week Range 0.48 - 19.08
  • Volume 39
  • Avg. Volume 2,517
  • Market Cap (intraday) 22.221M
  • Beta (5Y Monthly) 0.27
  • PE Ratio (TTM) --
  • EPS (TTM) -4.60
  • Earnings Date May 10, 2024 - May 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.00

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

www.zivobioscience.com

8

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZIVO

ZIVO Bioscience Announces Reverse Stock Split

Performance Overview: ZIVO

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZIVO
566.67%
S&P 500
6.37%

1-Year Return

ZIVO
55.11%
S&P 500
22.75%

3-Year Return

ZIVO
925.64%
S&P 500
21.38%

5-Year Return

ZIVO
1,011.11%
S&P 500
72.95%

Compare To: ZIVO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZIVO

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    22.22M

  • Enterprise Value

    22.29M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    488.97

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    806.26

  • Enterprise Value/EBITDA

    -3.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -338.92%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    27.65k

  • Net Income Avi to Common (ttm)

    -7.78M

  • Diluted EPS (ttm)

    -4.60

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    274.38k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.86M

Research Analysis: ZIVO

Analyst Price Targets

12.00
12.00 Average
8.00 Current
12.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ZIVO

Fair Value

8.00 Current
 

Dividend Score

0 Low
ZIVO
Sector Avg.
100 High
 

Hiring Score

0 Low
ZIVO
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ZIVO
Sector Avg.
100 High
 

People Also Watch